2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Terminated
1
Enrolling by invitation
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Genitourinary
3
Lymphoid
2
Head & Neck
2
Gynecologic
2
Gastrointestinal
2
Dermatologic
2
CNS
2
Breast
2
Thoracic
1
Plasma cell
1
Other hematologic neoplasm
1
Classical hematology
1
Conditions
Breast Neoplasms
13132
Triple Negative Breast Neoplasms
1149
Neoplasms
749
Ovarian Neoplasms
680
Neoplasm Metastasis
590
Lung Neoplasms
582
Colorectal Neoplasms
580
Prostatic Neoplasms
560
Carcinoma, Non-Small-Cell Lung
535
Pancreatic Neoplasms
380
Melanoma
366
Stomach Neoplasms
350
Colonic Neoplasms
330
Motor Activity
285
Breast Neoplasms, Male
285
Carcinoma, Intraductal, Noninfiltrating
277
Uterine Cervical Neoplasms
267
Head and Neck Neoplasms
266
Endometrial Neoplasms
256
Carcinoma, Renal Cell
216
Sarcoma
203
Urinary Bladder Neoplasms
192
Squamous Cell Carcinoma of Head and Neck
192
Lymphedema
190
Esophageal Neoplasms
189
Breast Carcinoma In Situ
189
Brain Neoplasms
183
Fatigue
166
Carcinoma, Ovarian Epithelial
151
Small Cell Lung Carcinoma
148
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Macular Degeneration
×
Breast
×
Clear all
NCT06583395
2024-11-01
QUANTUM
VitaMed Research LLC
Enrolling by invitation
3,000 enrolled
NCT02626377
2023-10-23
ICE
Centre Hospitalier Universitaire de Besancon
Phase NA
Terminated
186 enrolled